P0 02 Pill - white oval, 19mm
Pill with imprint P0 02 is White, Oval and has been identified as Doxycycline Hyclate Delayed-Release 200 mg. It is supplied by Solco Healthcare U.S., LLC.
Doxycycline is used in the treatment of Actinomycosis; Acne; Amebiasis; Anthrax; Gonococcal Infection, Uncomplicated and belongs to the drug classes miscellaneous antimalarials, tetracyclines. There is positive evidence of human fetal risk during pregnancy. Doxycycline 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for P0 02

Doxycycline Hyclate Delayed-Release
- Imprint
- P0 02
- Strength
- 200 mg
- Color
- White
- Size
- 19.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Miscellaneous antimalarials, Tetracyclines
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Solco Healthcare U.S., LLC
- Manufacturer
- Zhejiang Huahai Pharmaceutical Co., Ltd.
- National Drug Code (NDC)
- 43547-0325
- Inactive Ingredients
-
lactose monohydrate,
microcrystalline cellulose,
sodium lauryl sulfate,
sodium chloride,
magnesium silicate,
crospovidone,
magnesium stearate,
povidone,
hypromellose phthalate (31% phthalate, 170 cst),
triethyl citrate,
mannitol
Note: Inactive ingredients may vary.
Related images for "P0 02"
More about doxycycline
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,633)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: miscellaneous antimalarials
- Breastfeeding
- En español
Patient resources
Other brands
Vibramycin, Monodox, Doryx, Vibra-Tabs, ... +8 more
Professional resources
- Doxycycline monograph
- Doxycycline (Topical) (AHFS Monograph)
- Doxycycline Hyclate (EENT) (AHFS Monograph)
- Doxycycline (FDA)
- Doxycycline Delayed Release Capsule (FDA)
Other brands
Vibramycin, Monodox, Doryx, Doxy 100, ... +7 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.